Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis

Anticancer Research

Volumn 30, Issue 11, 2010, Pages 4443-4449

  Yanagisawa, Nobuyuki ^a   Yamashita, Kazuya ^b   Kuba, Tatsuru ^b   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cholecystitis; Direct sequencing; Gallbladder carcinoma; PCR SSCP; TP53; Transition mutations

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER TISSUE; CHOLECYSTECTOMY; CHRONIC CHOLECYSTITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA EXTRACTION; EPITHELIUM CELL; FEMALE; GALLBLADDER CANCER; GENE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SUPERNATANT;

ADULT; AGED; AGED, 80 AND OVER; CHOLECYSTECTOMY; CHOLECYSTITIS; CHRONIC DISEASE; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78650250371     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Levy AD, Murakata LA and Rohrmann CA Jr.: Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 21: 295-314; questionnaire, 549-255, 2001.
2. Yamashita K, Kida Y, Shinoda H, Kida M and Okayasu I: K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination. Jpn J Cancer Res 90: 240-248, 1999. (Pubitemid 29112326)
3. Yamashita K, Kuba T, Shinoda H, Takahashi E and Okayasu I: Detection of K-ras point mutations in the supernatants of peritoneal and pleural effusions for diagnosis complementary to cytologic examination. Am J Clin Pathol 109: 704-711, 1998. (Pubitemid 28247269)
4. Itoi T, Takei K, Shinohara Y, Takeda K, Nakamura K, Horibe T, Sanada A, Ohno H, Matsubayashi H, Saito T and Watanabe H: K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers. Pathol Int 49: 30-37, 1999. (Pubitemid 29421945)
5. Kim YT, Kim J, Jang YH, Ue WJ, Ryu JK, Park YK, Kim SW, Kim WH, Yoon YB and Kim CY: Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. Cancer Lett 169: 59-68, 2001. (Pubitemid 32532097)
6. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK and Williams CB: Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 31: 800-806, 1990.
7. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N and Sitas F: Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302: 1302-1305, 1991.
8. Okayasu I, Fujiwara M, Hara Y, Tanaka Y and Rose NR: Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African-Americans. Cancer 76: 2312-2318, 1995.
9. Albores-Saavedra J, de Jesus Manrique J, Angeles-Angeles A and Henson DE: Carcinoma in situ of the gallbladder. A clinicopathologic study of 18 cases. Am J Surg Pathol 8: 323-333, 1984.
10. WAF1 expression in chronic cholecystitis: comparison with background mucosa of gallbladder carcinomas. Histopathology 36: 54-61, 2000. (Pubitemid 30055424)
11. Yanagisawa N, Mikami T, Yamashita K and Okayasu I: Microsatellite instability in chronic cholecystitis is indicative of an early stage in gallbladder carcinogenesis. Am J Clin Pathol 120: 413-417, 2003. (Pubitemid 37295113)
12. Semba S, Yokozaki H, Yamamoto S, Yasui W and Tahara E: Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 77: 1620-1627, 1996. (Pubitemid 26111843)
13. Kashiwagi K, Watanabe M, Ezaki T, Kanai T, Ishii H, Mukai M and Hibi T: Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis. Br J Cancer 82: 1814-1818, 2000.
14. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggitt RC and Boland CR: Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 56: 1237-1240, 1996.
15. Matsumoto N, Yoshida T and Okayasu I: High epithelial and stromal genetic instability of chromosome 17 in ulcerative colitis-associated carcinogenesis. Cancer Res 63: 6158-6161, 2003. (Pubitemid 37255156)
16. Brentnall TA, Chen R, Lee JG, Kimmey MB, Bronner MP, Haggitt RC, Kowdley KV, Hecker LM and Byrd DR: Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55: 4264-4267, 1995.
17. Yamashita K, Tatebayashi T, Shinoda H and Okayasu I: Simplified rapid non-radioactive PCR-SSCP method applied to K-ras mutation analysis. Pathol Int 46: 801-804, 1996.
18. Moreno M, Pimentel F, Gazdar AF, Wistuba, II and Miquel JF: TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma. Ann Hepatol 4: 192-199, 2005.
19. Matsubara T, Funabiki T, Jinno O, Sakurai Y, Hasegawa S, Imazu H and Ochiai M: p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 6: 286-293, 1999.
20. Matsubara T, Sakurai Y, Zhi LZ, Miura H, Ochiai M and Funabiki T: K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 9: 312-321, 2002.
21. Soussi T, Kato S, Levy PP and Ishioka C: Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Hum Mutat 25: 6-17, 2005.
22. Nagahashi M, Ajioka Y, Lang I, Szentirmay Z, Kasler M, Nakadaira H, Yokoyama N, Watanabe G, Nishikura K, Wakai T, Shirai Y, Hatakeyama K and Yamamoto M: Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. World J Gastroenterol 14: 70-75, 2008.
23. Yokoyama N, Hitomi J, Watanabe H, Ajioka Y, Pruyas M, Serra I, Shirai Y and Hatakeyama K: Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile. Cancer Epidemiol Biomarkers Prev 7: 297-301, 1998.
24. Lea IA, Jackson MA, Li X, Bailey S, Peddada SD and Dunnick JK: Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis 28: 1851-1858, 2007.
25. Pfeifer GP and Besaratinia A: Mutational spectra of human cancer. Hum Genet 125: 493-506, 2009.
26. Rideout WM, 3rd, Coetzee GA, Olumi AF and Jones PA: 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249: 1288-1290, 1990.
27. Yoshida T, Mikami T, Mitomi H and Okayasu I: Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts. J Pathol 199: 166-175, 2003.
28. Murakami K, Fujioka T, Okimoto T, Mitsuishi Y, Oda T, Nishizono A and Nasu M: Analysis of p53 gene mutations in Helicobacter pylori-associated gastritis mucosa in endoscopic biopsy specimens. Scand J Gastroenterol 34: 474-477, 1999.
29. Yanagisawa N, Mikami T, Saegusa M and Okayasu I: More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages. Cancer Res 61: 19-22, 2001.
30. Roa I, de Aretxabala X, Araya JC and Roa J: Preneoplastic lesions in gallbladder cancer. J Surg Oncol 93: 615-623, 2006.
31. Hayashi K and Yandell DW: How sensitive is PCR-SSCP? Hum Mutat 2: 338-346, 1993.